Skip to main content
VIKAS LIFECARE LIMITED logo

VIKAS LIFECARE LIMITED — Investor Relations & Filings

Ticker · VIKASLIFE ISIN · INE161L01027 LEI · 9845008856U9D9DABE98 BSE.NS Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2022-07-18 Regulatory Filings
Country IN India
Listing BSE.NS VIKASLIFE

About VIKAS LIFECARE LIMITED

https://www.vikaslifecarelimited.com

Vikas Lifecare Limited is a diversified enterprise specializing in the manufacturing and trading of polymer and rubber compounds, specialty additives, and chemicals. The company produces high-performance polymer compounds utilized in sectors such as footwear, automotive, and infrastructure. Beyond its core chemical business, it has expanded into the Fast-Moving Consumer Goods (FMCG) and agro-products markets, focusing on the processing and distribution of premium food products. The company also provides infrastructure solutions, specifically in the domain of smart gas metering. A key aspect of its operations is the integration of recycled materials into its production cycles, reflecting a commitment to sustainable manufacturing. Its strategic focus involves vertical integration and portfolio diversification to address evolving industrial and consumer demands.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial results/Other business matters
Regulatory Filings Classification · 100% confidence The document text is extremely short (63 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of content, this cannot be classified as a report or detailed filing. It fits best as a Regulatory Filing (RNS) which is the fallback category for miscellaneous or non-informative filings.
2022-07-18 English
General updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, certifying details of securities dematerialized and rematerialized for the quarter ended June 30, 2022. It is addressed to stock exchanges and the company secretary, confirming compliance with regulatory requirements. The document is short (2436 characters) and primarily a certification letter rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report publication but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and certification documents that do not fit other specific categories.
2022-07-08 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Listing Compliance Department of stock exchanges, notifying the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations. It specifies the period during which insiders are prohibited from trading securities due to the upcoming declaration of quarterly financial results. The document does not contain any financial data, results, or detailed reports but is an announcement related to trading restrictions ahead of financial disclosures. Therefore, it is neither a financial report nor a detailed regulatory filing but an announcement related to compliance and trading restrictions. This type of document best fits under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-06-30 English
General updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, addressed to stock exchanges. It informs about a business decision to reduce the company's stake in another company, Advik Laboratories Limited, while continuing to hold a significant portion. The document is a regulatory announcement about a change in shareholding stakes, not a full financial report or detailed filing. It does not contain financial statements or detailed analysis, nor is it a report publication announcement. The content fits best under a regulatory announcement category related to shareholding changes but does not indicate crossing major shareholding thresholds. It is not a major shareholding notification (MRQ) since it mentions a reduction but no threshold crossing. It is also not a director's dealing (DIRS) as it concerns company stakes, not personal trades. The best fit is Regulatory Filings (RNS) as a general regulatory announcement about business and shareholding changes under SEBI regulations.
2022-06-22 English
General updates
Regulatory Filings Classification · 95% confidence The document is a media release announcing the addition of new products (Almonds and Walnuts) to the company's Agro-Products division. It is addressed to stock exchanges under SEBI regulations and includes forward-looking statements about business strategy and product offerings. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The document is a corporate announcement about business activities and product expansion, not a financial report or regulatory filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2022-06-12 English
Related Party Transaction
Regulatory Filings Classification · 95% confidence The document is a compliance disclosure pursuant to Regulation 23(9) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. It provides detailed information on related party transactions for the half year ended March 31, 2022. The document is addressed to stock exchanges and includes names of related parties, nature of transactions, and transaction amounts. It is not a full financial report but a regulatory compliance disclosure focused on related party transactions. The document length is 3237 characters, which is relatively short and focused on a specific regulatory requirement. This fits best under Regulatory Filings (RNS), as it is a regulatory announcement and disclosure rather than a full report like an Annual or Interim Report.
2022-06-11 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.